Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

583
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
583
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

326
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
326
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

701
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
701
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

307
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
307
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

531
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
531
Dialysis01:27

Dialysis

1.1K
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Anemia in Patients with Chronic Kidney Disease: A Pre-Post Observational Analysis.

Medical sciences (Basel, Switzerland)·2026
Same author

Unveiling the Bioactive Potential of the Aerial Parts of Balkan <i>Achillea clypeolata</i>: Comparison with Officinal <i>Achillea millefolium</i>.

Pharmaceutics·2026
Same author

Symmetry-enforced topological Dirac semimetal for giant spin-orbit torque with ultralow power dissipation.

National science review·2026
Same author

Kidney Transplantation in Western Balkans: A Regional Blueprint for Access, Capacity, and Equity.

Transplant international : official journal of the European Society for Organ Transplantation·2026
Same author

Clinical Behavior of Aggressive Variants of Papillary Thyroid Carcinoma: A Retrospective Case-Control Study.

Cancers·2026
Same author

<i>Sclerotinia</i> Species Causing Lettuce Drop Disease in Serbia.

Microorganisms·2026

Related Experiment Video

Updated: Jan 10, 2026

A Murine Model of Hemodialysis Access-Related Hand Dysfunction
08:39

A Murine Model of Hemodialysis Access-Related Hand Dysfunction

Published on: May 31, 2022

2.0K

Magnesium in chronic hemodialysis.

Marija Milinkovic, Lara Hadzi Tanovic, Aleksandra Jovanovic

    Clinical Nephrology
    |November 20, 2025
    PubMed
    Summary

    Higher dialysate magnesium (dMg) levels in hemodialysis patients safely increase plasma magnesium (pMg) without affecting the QT interval. This approach may help manage secondary hyperparathyroidism in patients undergoing hemodialysis.

    More Related Videos

    Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
    07:11

    Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

    Published on: July 19, 2018

    15.9K
    A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
    06:27

    A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

    Published on: July 20, 2022

    3.1K

    Related Experiment Videos

    Last Updated: Jan 10, 2026

    A Murine Model of Hemodialysis Access-Related Hand Dysfunction
    08:39

    A Murine Model of Hemodialysis Access-Related Hand Dysfunction

    Published on: May 31, 2022

    2.0K
    Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
    07:11

    Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

    Published on: July 19, 2018

    15.9K
    A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
    06:27

    A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

    Published on: July 20, 2022

    3.1K

    Area of Science:

    • Nephrology
    • Cardiovascular Medicine
    • Clinical Chemistry

    Background:

    • Patients on hemodialysis (HD) face elevated risks of mortality, with low plasma magnesium (pMg) linked to arrhythmias.
    • Understanding the impact of dialysate magnesium (dMg) on pMg levels is crucial for patient management.

    Purpose of the Study:

    • To investigate the relationship between varying dMg concentrations and clinical characteristics in chronic HD patients.
    • To assess the effect of dMg on pMg levels and secondary hyperparathyroidism markers.

    Main Methods:

    • An observational study involving 103 chronic HD patients.
    • Patients were categorized into two groups based on dMg: 0.5 mmol/L (Group 1) and 1 mmol/L (Group 2).
    • Clinical data, including pMg, intact parathyroid hormone (iPTH), and QT interval, were collected.

    Main Results:

    • Higher dMg (1 mmol/L) significantly increased pMg concentrations compared to lower dMg (0.5 mmol/L).
    • The low dMg group exhibited significantly lower pMg and higher iPTH levels.
    • No significant differences were observed in age, HD duration, Qb, Kt/V, dCa, or mean QT interval between the groups.

    Conclusions:

    • Increasing dMg concentrations is a safe method to raise pMg levels in HD patients.
    • Higher dMg may offer benefits in controlling secondary hyperparathyroidism.
    • This intervention does not appear to adversely affect the QT interval.